Promising Drug, Phase 2 Trial, New Hope for FAP Biodexa Pharmaceuticals PLC is a clinical-stage biologic (biopharmaceutical) drug company. It's known for developing the kind of medicines that help people suffering from otherwise hard-to-treat conditions. The article looks at a Phase 2 trial using eRapa to treat Familial Adenomatous Polyposis (FAP). This genetic condition causes…